| Schedule of Earning Per Share |
Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive.
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Net loss computation of basic and diluted net loss per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
(2,519,158 |
) |
|
$ |
7,422 |
|
|
$ |
(6,273,817 |
) |
|
$ |
507,635 |
|
| Less: Redemption of Series D Preferred Stock deemed dividend |
|
|
- |
|
|
|
- |
|
|
|
(1,295,294 |
) |
|
|
- |
|
| Less: Common stock deemed dividend (inducement cost) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,137,190 |
) |
| Net loss attributable to common stockholders |
|
$ |
(2,519,158 |
) |
|
$ |
7,422 |
|
|
$ |
(7,569,111 |
) |
|
$ |
(1,629,555 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic net loss per common share |
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.49 |
) |
|
$ |
(1.06 |
) |
| Basic weighted average common shares outstanding |
|
|
22,209,152 |
|
|
|
1,904,270 |
|
|
|
15,440,558 |
|
|
|
1,538,834 |
|
| Diluted net loss per common share |
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.49 |
) |
|
$ |
(1.05 |
) |
| Diluted weighted average common shares outstanding |
|
|
22,209,152 |
|
|
|
1,904,270 |
|
|
|
15,440,558 |
|
|
|
1,551,618 |
|
|
| Schedule of Potential Dilutive Securities |
Potentially dilutive securities that are not
included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows as of June 30, (in
common equivalent shares):
| |
|
2020 |
|
|
2019 |
|
| Preferred shares |
|
|
- |
|
|
|
1,886,000 |
|
| Warrants |
|
|
21,925,102 |
|
|
|
3,299,569 |
|
| Series A & B Notes |
|
|
213,105 |
|
|
|
- |
|
| Options and restricted stock units |
|
|
1,018,853 |
|
|
|
1,063,419 |
|
| Total anti-dilutive weighted average shares |
|
|
23,157,060 |
|
|
|
6,248,988 |
|
|